Adherence to treatment with second-line therapies, dasatinib and nilotinib, in patients with chronic myeloid leukemia. (Q53139833)
Jump to navigation
Jump to search
scientific article published on 9 January 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | Adherence to treatment with second-line therapies, dasatinib and nilotinib, in patients with chronic myeloid leukemia. |
scientific article published on 9 January 2012 |
Statements
Adherence to treatment with second-line therapies, dasatinib and nilotinib, in patients with chronic myeloid leukemia. (English)
Marianne Ulcickas Yood
Susan A Oliveria
Mark Cziraky
Ishan Hirji
Muhammad Hamdan
Catherine Davis
9 January 2012
28
2
213-219